These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 26603890)

  • 21. Investigation of the Changes in Aerosolization Behavior Between the Jet-Milled and Spray-Dried Colistin Powders Through Surface Energy Characterization.
    Jong T; Li J; Morton DA; Zhou QT; Larson I
    J Pharm Sci; 2016 Mar; 105(3):1156-63. PubMed ID: 26886330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Delivery of High-Dose Dry Powder Antibiotics by a Low-Cost Generic Inhaler.
    Parumasivam T; Leung SS; Tang P; Mauro C; Britton W; Chan HK
    AAPS J; 2017 Jan; 19(1):191-202. PubMed ID: 27679516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhalable combination powder formulations of phage and ciprofloxacin for P. aeruginosa respiratory infections.
    Lin Y; Chang RYK; Britton WJ; Morales S; Kutter E; Li J; Chan HK
    Eur J Pharm Biopharm; 2019 Sep; 142():543-552. PubMed ID: 31398437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physico-Chemical Properties, Aerosolization and Dissolution of Co-Spray Dried Azithromycin Particles with L-Leucine for Inhalation.
    Mangal S; Nie H; Xu R; Guo R; Cavallaro A; Zemlyanov D; Zhou QT
    Pharm Res; 2018 Jan; 35(2):28. PubMed ID: 29374368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spray-freeze-dried inhalable composite microparticles containing nanoparticles of combinational drugs for potential treatment of lung infections caused by Pseudomonas aeruginosa.
    Yu S; Pu X; Ahmed MU; Yu HH; Mutukuri TT; Li J; Zhou QT
    Int J Pharm; 2021 Dec; 610():121160. PubMed ID: 34624446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and Evaluation of Chitosan Microparticles Based Dry Powder Inhalation Formulations of Rifampicin and Rifabutin.
    Pai RV; Jain RR; Bannalikar AS; Menon MD
    J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):179-95. PubMed ID: 26406162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physicochemical characterization and stability of rifampicin liposome dry powder formulations for inhalation.
    Changsan N; Chan HK; Separovic F; Srichana T
    J Pharm Sci; 2009 Feb; 98(2):628-39. PubMed ID: 18484099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simultaneous Particle Size Reduction and Homogeneous Mixing to Produce Combinational Powder Formulations for Inhalation by the Single-Step Co-Jet Milling.
    Ling J; Mangal S; Park H; Wang S; Cavallaro A; Zhou QT
    J Pharm Sci; 2019 Sep; 108(9):3146-3151. PubMed ID: 31112716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel inhaled multi-pronged attack against respiratory bacteria.
    Lee SH; Teo J; Heng D; Zhao Y; Ng WK; Chan HK; Tan LT; Tan RB
    Eur J Pharm Sci; 2015 Apr; 70():37-44. PubMed ID: 25612805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective effect of sodium stearate on the moisture-induced deterioration of hygroscopic spray-dried powders.
    Yu J; Romeo MC; Cavallaro AA; Chan HK
    Int J Pharm; 2018 Apr; 541(1-2):11-18. PubMed ID: 29454904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhalable formulations of rifampicin by spray drying of supersaturated aqueous solutions.
    Berkenfeld K; McConville JT; Lamprecht A
    Eur J Pharm Biopharm; 2020 Aug; 153():14-22. PubMed ID: 32446961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proof-of-Principle Study in a Murine Lung Infection Model of Antipseudomonal Activity of Phage PEV20 in a Dry-Powder Formulation.
    Chang RYK; Chen K; Wang J; Wallin M; Britton W; Morales S; Kutter E; Li J; Chan HK
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Production of highly stable spray dried phage formulations for treatment of Pseudomonas aeruginosa lung infection.
    Chang RY; Wong J; Mathai A; Morales S; Kutter E; Britton W; Li J; Chan HK
    Eur J Pharm Biopharm; 2017 Dec; 121():1-13. PubMed ID: 28890220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel dry powder inhalable formulation incorporating three first-line anti-tubercular antibiotics.
    Chan JG; Chan HK; Prestidge CA; Denman JA; Young PM; Traini D
    Eur J Pharm Biopharm; 2013 Feb; 83(2):285-92. PubMed ID: 22982733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dry powder aerosols to co-deliver antibiotics and nutrient dispersion compounds for enhanced bacterial biofilm eradication.
    Sommerfeld Ross S; Gharse S; Sanchez L; Fiegel J
    Int J Pharm; 2017 Oct; 531(1):14-23. PubMed ID: 28826725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A study on polymorphic forms of rifampicin for inhaled high dose delivery in tuberculosis treatment.
    Khadka P; Hill PC; Zhang B; Katare R; Dummer J; Das SC
    Int J Pharm; 2020 Sep; 587():119602. PubMed ID: 32663580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Dry powder inhalers in cystic fibrosis].
    Steinkamp G
    Pneumologie; 2014 Jun; 68(6):378-85. PubMed ID: 24664997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [In vitro activities of colistin combinations against Pseudomonas aeruginosa isolated from the intensive care unit].
    López-Fabal F; Culebras E; Bonilla I; Gómez M; Picazo JJ
    Rev Esp Quimioter; 2008 Sep; 21(3):189-93. PubMed ID: 18792821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergistic combination dry powders for inhaled antimicrobial therapy: formulation, characterization and in vitro evaluation.
    Lee SH; Teo J; Heng D; Ng WK; Chan HK; Tan RB
    Eur J Pharm Biopharm; 2013 Feb; 83(2):275-84. PubMed ID: 23010564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.